Abstract
Successful donor egg IVF depends on effective suppression of the HPO axis to allow cycle synchronization of donors and recipients. Daily self-administration of OCPs is often used to facilitate cycle programming and scheduling. This approach may be hampered by lack of patient compliance. NuvaRing, a three week sustained release estrogen-progestin vaginal ring, may be placed after onset of menses by physician or nursing personnel. The objective of our study was to compare NuvaRing to OCPs for HPO axis suppression in egg donor cycles.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
